Progression from excessive to deficient syndromes in chronic hepatitis B: A dynamical network analysis of miRNA array data

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Qi Long ^a   Lu, Yi Yu ^a   Zhang, Gui Biao ^a   Song, Ya Nan ^a   Zhou, Qian Mei ^a   Zhang, Hui ^a   Zhang, Wei ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; ARTICLE; CARCINOGENESIS; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASES; FEMALE; GENE EXPRESSION; HEPATITIS B; HUMAN; LIVER DEPRESSION AND SPLEEN DEFICIENCY SYNDROME; LIVER GALLBLADDER DAMPNESS HEAT SYNDROME; LIVER KIDNEY YIN DEFICIENCY SYNDROME; MALE; PRIORITY JOURNAL;

EID: 84877255706     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/945245     Document Type: Article

References (33)

1. Tong M. J., Hsu L., Chang P. W., Blatt L. M., Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update. Journal of Gastroenterology and Hepatology 2011 26 5 829 835 2-s2.0-79954552745 10.1111/j.1440-1746.2011.06623.x
2. Hsu A., Lai C. L., Yuen M. F., Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection. Current Hepatitis Reports 2011 10 2 106 111 2-s2.0-79957508039 10.1007/s11901-011-0094-2
3. Chiba M., Katayama K., Takeda R., Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine. Hepatology Research 2012 10.1111/j.1872-034X.2012.01093.x
4. Cui X., Wang Y., Kokudo N., Fang D., Tang W., Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Bioscience Trends 2010 4 2 39 47 2-s2.0-77956893733
5. Jia W., Gao W. Y., Yan Y. Q., Wang J., Xu Z. H., Zheng W. J., Xiao P. G., The rediscovery of ancient Chinese herbal formulas. Phytotherapy Research 2004 18 8 681 686 2-s2.0-4944262480 10.1002/ptr.1506 (Pubitemid 39329723)
6. Ding W. J., Zeng Y. Z., Li W. H., Zhang T. E., Liu W. W., Teng X. K., Ma Y. X., Yan S. L., Wan J. M. F., Wang M. Q., Identification of linkage disequilibrium SNPs from a Kidney-yang deficiency syndrome pedigree. American Journal of Chinese Medicine 2009 37 3 427 438 2-s2.0-68149171589 10.1142/S0192415X09006953
7. Zeng X. X., Bian Z. X., Wu T. X., Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: a systematic review. The American Journal of Chinese Medicine 2011 39 6 1061 1074 10.1142/ S0192415X11009408
8. Guo Z., Yu S., Guan Y., Molecular mechanisms of same TCM syndrome for different diseases and different TCM syndrome for same disease in chronic hepatitis B and liver cirrhosis. Evidence-Based Complementary and Alternative Medicine 2012 2012 120350 10.1155/2012/120350
9. Esquela-Kerscher A., Slack F. J., Oncomirs-microRNAs with a role in cancer. Nature Reviews Cancer 2006 6 4 259 269 2-s2.0-33645294070 10.1038/nrc1840
10. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002
11. Hou J., Lin L., Zhou W., Wang Z., Ding G., Dong Q., Qin L., Wu X., Zheng Y., Yang Y., Tian W., Zhang Q., Wang C., Zhang Q., Zhuang S. M., Zheng L., Liang A., Tao W., Cao X., Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011 19 2 232 243 2-s2.0-79751484450 10.1016/j.ccr.2011.01.001
12. Zhang H., Li Q. Y., Guo Z. Z., Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World Journal of Gastroenterology 2012 18 37 5188 5196
13. Ma Z., Guo W., Niu H. J., Transcriptome network analysis reveals potential candidate genes for esophageal squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention 2012 13 3 767 773 10.7314/APJCP.2012.13.3.767
14. He D., Liu Z. P., Chen L., Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics 2011 12 592 10.1186/1471-2164-12-592
15. Jia P., Wang L., Fanous A. H., Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLOS Computational Biology 2012 8 7 e1002587
16. Liu Z. P., Wang Y., Zhang X. S., Network-based analysis of complex diseases. IET Systems Biology 2012 6 1 22 33 10.1049/iet-syb.2010.0052
17. Hepatology C. S. O., Association C. M., Diseases C. S. O. I., Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chinese Medical Journal 2007 120 24 2159 2173
18. The standards of TCM differential syndromes of viral hepatitis. Defined in December 1991 by Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association
19. Vergoulis T., Vlachos I. S., Alexiou P., TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Research 2012 40 D222 D229
20. Wang X., El Naqa I. M., Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008 24 3 325 332 2-s2.0-38849145861 10.1093/bioinformatics/btm595 (Pubitemid 351189007)
21. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
22. Huang D. W., Sherman B. T., Lempicki R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009 37 1 1 13 2-s2.0-58549112996 10.1093/nar/gkn923
23. Zheng S., Tansey W. P., Hiebert S. W., Zhao Z., Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Medical Genomics 2011 4 62 2-s2.0-79961125191 10.1186/1755-8794-4-62
24. Krek A., Grun D., Poy M. N., Combinatorial microRNA target predictions. Nature Genetics 2005 37 5 495 500 10.1038/ng1536 (Pubitemid 40617277)
25. Miller J. A., Horvath S., Geschwind D. H., Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proceedings of the National Academy of Sciences of the United States of America 2010 107 28 12698 12703 2-s2.0-77955454185 10.1073/pnas.0914257107
26. He D., Liu Z. P., Honda M., Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. Journal of Molecular Cell Biology 2012 4 3 140 152 10.1093/jmcb/mjs011
27. Chen L., Liu R., Liu Z. P., Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Surface Science Reports 2012 2 342 10.1038/srep00342
28. Dewey F. E., Perez M. V., Wheeler M. T., Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circulation 2011 4 1 26 35 10.1161/CIRCGENETICS.110.941757
29. Tsai W. L., Chung R. T., Viral hepatocarcinogenesis. Oncogene 2010 29 16 2309 2324 2-s2.0-77951622187 10.1038/onc.2010.36
30. Feitelson M. A., Lee J., Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Letters 2007 252 2 157 170 2-s2.0-34249303417 10.1016/j.canlet.2006.11.010 (Pubitemid 46809787)
31. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S., Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009 49 4 1098 1112 2-s2.0-65449154685 10.1002/hep.22749
32. Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Kaneko S., Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 2006 44 5 1122 1138 2-s2.0-33751001342 10.1002/hep.21383 (Pubitemid 44748364)
33. Spaziani A., Alisi A., Sanna D., Balsano C., Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. Journal of Biological Chemistry 2006 281 16 10983 10989 2-s2.0-33744958372 10.1074/jbc.M512536200 (Pubitemid 43855521)